Creating a cancer-free world. One person, one discovery at a time.
To eradicate cancer from individuals’ lives by creating knowledge and integrating groundbreaking research with excellence in education and patient-centered care
As the Midwest's first and Ohio's only fully dedicated cancer hospital and research institute, The Ohio State University Comprehensive Cancer Center–Arthur G. James Cancer Hospital and Solove Research Institute (OSUCCC–James) is one of the nation's premier cancer centers for the prevention, detection and treatment of cancer.
The OSUCCC–James is one of only 41 centers in the United States designated by the National Cancer Institute a Comprehensive Cancer Center. In addition, the OSUCCC–James is a founding member of the National Comprehensive Cancer Network (NCCN), an alliance of 21 of the world's leading cancer centers that develops clinical practice guidelines to improve the quality and effectiveness of care provided to patients with cancer.
The OSUCCC–James is the only cancer program in the country that features a National Cancer Institute (NCI)-designated comprehensive cancer center aligned with a nationally ranked academic medical center and a freestanding cancer hospital on the campus of one of the nation's largest public universities.
The cancer program at Ohio State encompasses nearly 300 comprehensive cancer center members from 11 of the 14 colleges at The Ohio State University. The OSUCCC–James' singular focus on cancer has led to multiple accomplishments that have changed the standards of care with respect to prevention, diagnosis and treatment, in a way that substantially improves outcomes for cancer patients.
In 2009, The Ohio State University Board of Trustees approved a $1 billion expansion of the cancer hospital and Medical Center facilities, including a new 276-bed* cancer hospital and critical care building. This expansion sets Ohio State apart as a national leader in innovative cancer care by supporting new, high-quality, patient-centered, personalized medicine. The new hospital will have increased capacity to help keep pace with the projected 21 percent growth in admissions during the next decade.
Click here for a downloadable PDF with additional information about our cancer program.
The Ohio State Cancer Program
OSU Comprehensive Cancer Center
Established in 1973 as a cancer center and receiving the NCI Comprehensive Cancer Center designation in 1976, the OSUCCC–James has six highly interactive cancer research programs that include nearly 300 leading cancer researchers and scientists from 11 of the 14 colleges at Ohio State.
Unprecedented programmatic funding and the recently announced $1 billion expansion of the cancer hospital, clinics and laboratories have fostered growth of scientific programs and the development of shared resources.
During the past 15 years, the OSUCCC – James has recruited some of the world’s leading cancer researchers and seen extraordinary growth in its science-based clinical programs. Because of that, Ohio State's National Cancer Institute (NCI) funding has more than quadrupled, making this University the 15th highest NCI-funded cancer program in the nation.
The 19 Shared Resources provide investigators with easy access to specialized technologies, services, methodologies and consultation that catalyze abilities to conduct cancer research. Through the leadership of skilled faculty and technicians, these shared resources provide cost-effective, reliable and quality services for our researchers.
Ohio States' Comprehensive Cancer Center–James Cancer Hospital
and Solove Research Institute
Ranked as one of the top cancer hospitals in the nation, the OSUCCC–James is the Midwest’s first freestanding cancer hospital. This 228-bed adult cancer clinical care facility is one of 11 DRG- or PPS-exempt institutions in the United States.
Our ability to translate groundbreaking cancer research into innovative patient care distinguishes The James as an academic medical institution and positions us for a leadership role in personalized medicine.
Our multidisciplinary and multimodality approach to cancer care includes disease-site groups in which surgical oncologists, medical oncologists, pathologists, radiologists, radiation oncologists, nurses, researchers and others collaborate to provide the latest in cancer diagnosis, treatment and prevention.
The hospital also includes a 24-bed bone marrow transplant unit, intra-operative radiation therapy, special isolation rooms, chemotherapy and special transfusion areas and specialized diagnostic equipment. It also has a 9-bed clinical trials unit for early phase investigational drug delivery. The OSUCCC–James is one of only seven centers in the country funded by the National Cancer Institute to conduct both phase I and phase II clinical trials on novel anticancer drugs.
Ambulatory patients access services from a variety of outpatient facilities located on campus and across central Ohio. In 2011, the 114,000 square foot Stefanie Spielman Comprehensive Breast Center opened near the hospital.
OSUCCC–James is fully accredited by the Joint Commission on Accreditation of Healthcare Organizations (JCAHO), the American College of Surgeons Commission on Cancer, and the Foundation for the Accreditation of Cellular Therapy. The OSUCCC–James is consistently ranked among the top hospitals in America by U.S.News & World Report and The Leapfrog Group. The OSUCCC–James was a founding member of the National Comprehensive Cancer Network and the Alliance of Dedicated Cancer Centers.
*This figure does not include ICU beds.